Company News

Company News
May 21, 2021
CORE ONE LABS PROVIDES CLARIFICATION ON TRADING ACTIVITY
Vancouver, British Columbia, Canada – May 21, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”). ...
Read more
Company News
May 13, 2021
CORE ONE LABS INC. PROVIDES UPDATE ON DEFAULT ANNOUNCEMENT PURSUANT TO NATIONAL POLICY 12-203 – MANAGEMENT CEASE TRADE ORDERS
Vancouver, British Columbia, Canada – May 13, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”). ...
Read more
Company News
May 06, 2021
Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease
Vancouver, British Columbia, Canada – May 6, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
May 05, 2021
World Renowned Physician Joins Core One Labs as Chief Medical Officer
Vancouver, British Columbia, Canada – May 5, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
May 04, 2021
Core One Labs Unaware of Any Material Change that Would Account for Significant Share Price Depreciation
Vancouver, British Columbia, Canada – May 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
May 04, 2021
Core One Labs Completes Milestone Acquisition of Akome Biotech
Vancouver, British Columbia, Canada – May 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research...
Read more